
AstraZeneca
AZNCF | OTC
$189.90
-$2.60 (-1.35%)
Mar 13, 2026, 9:30 AM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 5.49B | 5.84B | 6.17B | 6.33B | 7.83B | 5.37B |
Short-Term Investments | 166M | 20M | 239M | 69M | 160M | 849M |
Long-Term Investments | 1.73B | 1.66B | 903M | 1.17B | 987M | 610M |
Other Long-Term Assets | 1.3B | 2.71B | 1.15B | 1.07B | 1.05B | 1.65B |
Receivables | 8.3B | 8.41B | 9.98B | 8.78B | 5.65B | 5.18B |
Inventory | 5.28B | 5.42B | 4.7B | 8.98B | 4.02B | 3.19B |
Other Current Assets | 4.98B | 3.75B | 3.11B | 3.32B | 1.94B | 1.7B |
Total Current Assets | 25.83B | 25.05B | 22.59B | 26.24B | 19.54B | 15.56B |
Property-Plant & Equipment | 11.63B | 10.49B | 9.45B | 10.17B | 8.92B | 8.34B |
Goodwill & Intangibles | 58.2B | 58.14B | 59.13B | 62.38B | 32.79B | 32.5B |
Total Long-Term Assets | 78.21B | 76.07B | 73.89B | 79.12B | 47.19B | 45.81B |
Total Assets | 104.04B | 101.12B | 96.48B | 105.36B | 66.73B | 61.38B |
Account Payables | 3.64B | 3.27B | 2.55B | 2.82B | 2.35B | 1.77B |
Deferred Revenue | n/a | 148.79M | 181.98M | 1.01B | 1.63B | 28M |
Short-Term Debt | 2.16B | 5.13B | 6.27B | 2.66B | 2.23B | 1.86B |
Other Current Liabilities | 17.31B | 5.98B | 3.81B | 4.52B | 5.85B | 4.9B |
Total Current Liabilities | 27.87B | 30.54B | 26.29B | 22.59B | 20.31B | 18.12B |
Long-Term Debt | 26.51B | 22.33B | 23.91B | 29.72B | 19.8B | 17.89B |
Other Long-Term Liabilities | 4.37B | 5.37B | 8.5B | 13.01B | 10.49B | 10.28B |
Total Long-Term Liabilities | 35.3B | 31.41B | 33.13B | 43.48B | 30.78B | 28.66B |
Total Liabilities | 63.16B | 61.95B | 59.43B | 66.08B | 51.09B | 46.78B |
Total Debt | 30.11B | 28.62B | 29.23B | 30.78B | 20.38B | 18.23B |
Book Value | 40.87B | 39.17B | 37.06B | 39.29B | 15.64B | 14.6B |
Book Value Per Share | 26.17 | 25.07 | 23.76 | 27.53 | 11.91 | 11.22 |
Common Stock | 387.6M | 388M | 387M | 387M | 328M | 328M |
Retained Earnings | 3.16B | 4.52B | -574M | 1.71B | 5.3B | 2.81B |
Comprehensive Income | 1.56B | -949M | 1.63B | 1.59B | 1.58B | 1.6B |
Shareholders Equity | 40.79B | 39.14B | 37.04B | 39.27B | 15.62B | 13.13B |
Total Investments | 1.9B | 1.68B | 1.14B | 1.24B | 1.15B | 1.46B |
Add to Watchlist
Select watchlists to add or remove AZNCF